PQ BYPASS
PQ Bypass is a Silicon Valley-based medical device company working to transform the treatment of long-segment peripheral artery disease with minimally-invasive endovascular solutions. PQ Bypass is a former Company-In-Residence at the Fogarty Institute for Innovation and is operated by recognized leaders in the medical device industry. Our executive team members have held senior leadership positions at companies including Medtronic, Abbott, Johnson & Johnson, Covidien, and Stryker and also have extensive experience developing medical devices for venture-backed startups such as Evalve, AccessClosure, Altura, and DVI.
PQ BYPASS
Industry:
Clinical Trials Health Care Medical Medical Device
Founded:
2009-01-01
Address:
Sunnyvale, California, United States
Country:
United States
Website Url:
http://www.pqbypass.com
Total Employee:
11+
Status:
Active
Contact:
(408) 940-3520
Total Funding:
70.04 M USD
Technology used in webpage:
Euro SSL By Default IPv6 Cloudflare Hosting Cloudflare CDN Cloudflare Cloudflare DNS Cloudflare Network Error Logging
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Broncus Technologies
Broncus Technologies is a medical technology company developing minimally-invasive medical devices for emphysema and other lung diseases.
EBR Systems
EBR Systems is a provider of wireless cardiac pacing system for millions of patients suffering from cardiac rhythm diseases.
MediPrint Ophthalmics
MediPrint Ophthalmics is a clinical stage eye care pharmaceutical company.
Mercator MedSystems
Mercator MedSystems develops site-specific delivery devices for the treatment of vascular, oncologic, and regenerative diseases.
Minerva Surgical
Minerva Surgical is a medical device start-up company developing medical devices for women’s healthcare.
Current Advisors List
Current Employees Featured
Founder
Investors List
Seroba Life Sciences
Seroba Life Sciences investment in Private Equity Round - PQ Bypass
Deerfield Capital Management
Deerfield Capital Management investment in Private Equity Round - PQ Bypass
MedTech Venture Partners
MedTech Venture Partners investment in Private Equity Round - PQ Bypass
Key Employee Changes
| Date | New article |
|---|---|
| 2020-10-02 | PQ Bypass Appoints Heather Simonsen as Company President |
Official Site Inspections
http://www.pqbypass.com Semrush global rank: 8.67 M Semrush visits lastest month: 482
- Host name: 172.67.139.85
- IP address: 172.67.139.85
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "PQ Bypass"
PQ Bypass - Organized Arrangement
Them healthier and happier. Horse racing brings joy to many by offering thrilling experiences and a sense of community. Fans enjoy the excitement of races, the beauty of the horses, and the …See details»
PQ Bypass - Crunchbase Company Profile & Funding
PQ Bypass is a Silicon Valley-based medical device company working to transform the treatment of long-segment peripheral artery disease with minimally-invasive endovascular solutions.See details»
Endologix LLC Announces Acquisition of PQ Bypass, Inc.
Apr 13, 2021 Company Expands Vascular Reach to Treat Unmet Needs of Both AAA and PAD Patients. IRVINE, Calif.—(BUSINESS WIRE)—April 13, 2021—Endologix LLC, a leader in the …See details»
Endologix LLC Announces Acquisition of PQ Bypass, Inc.
Apr 13, 2021 IRVINE, Calif.--(BUSINESS WIRE)--Endologix LLC, a leader in the treatment of vascular disease, today announced it has completed the acquisition of PQ Bypass, Inc., a privately held medical ...See details»
PQ Bypass Acquired by Endologix for its Innovative Procedure
May 26, 2021 Sobrato Pavilion 2495 Hospital Drive, Suite 300 Mountain View, CA 94040 (650) 293-0770 [email protected]See details»
Working At PQ Bypass: Company Overview and Culture - Zippia
Pqbypass.com. Organization Type. Private. CEO. Richard Ferrari. Social Media. PQ Bypass, Inc. is a Silicon Valley-based medical device company working to transform the treatment of long …See details»
PQ Bypass, Inc. - Radcliffe Vascular
PQ Bypass, Inc. is a Silicon Valley-based medical device company working to transform the treatment of long-segment femoropopliteal disease with minimally-invasive endovascular …See details»
Endologix Acquires PQ Bypass - Endovascular Today
April 13, 2021—Endologix LLC announced it has completed the acquisition of PQ Bypass, Inc., which is based in Miliptas, California. Endologix isSee details»
PQ Bypass Inc. | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Endologix acquires PQ Bypass, developer of percutaneous ... - Healio
Apr 16, 2021 Endologix announced it completed the acquisition of PQ Bypass, a medical technology company that developed a platform for percutaneous femoral-popliteal bypass for …See details»
PQ Bypass - Craft
PQ Bypass is a medical device company, which aims to transform the treatment of long-segment femoropopliteal disease. The Company's products include Detour System, a novel approach …See details»
PQ Bypass Receives FDA “Breakthrough Device ... - Business Wire
Victoria Versprille, 908-328-5787, [email protected]. Release Summary. Designation Expedites Physician Access to Device for Patients with Extremely Long and Complex SFA …See details»
PQ Bypass Announces 100th Patient in Clinical Study to Evaluate ...
Jan 10, 2020 MILPITAS, Calif.--(BUSINESS WIRE)--Silicon Valley-based medical device company PQ Bypass announced today the 100th patient in the DETOUR2 Clinical Trial, which …See details»
PQ Bypass's Detour Device Receives FDA ... - Endovascular Today
September 2, 2020—PQ Bypass Inc, announced that it has received Breakthrough Device designation from the FDA for the company's Detour system, a fully percutaneous femoral …See details»
PQ Bypass Receives FDA “Breakthrough Device ... - Cardiac …
Victoria Versprille, 908-328-5787, [email protected]. FDA; PQ Bypass; Ken Dropiewski. Ken has been in the cardiac, vascular, and interventional space for over 20 years. He is a …See details»
One-year results from the DETOUR I trial of the PQ Bypass …
Sep 6, 2019 K.O. and K.N. are employees of Syntactx, a clinical research organization that received research funding from PQ Bypass and other manufacturers of lower extremity …See details»
PQ Bypass receives FDA breakthrough device designation for its …
Sep 3, 2020 An illustration of a completed Detour procedure within the superficial femoral artery and the femoral vein. PQ Bypass has announced that they received breakthrough device …See details»
PQ Bypass Completes Enrollment in DETOUR2 Percutaneous …
Oct 6, 2020 Media Contact: Victoria Versprille [email protected] 908-328-5787 Release Summary. Med Tech company PQ Bypass announces completion of enrollment in …See details»
24-Month Outcomes Presented for PQ Bypass Detour Device
November 7, 2020—The Detour system (PQ Bypass) for percutaneous femoropopliteal bypass was evaluated for safety and effectiveness in the DETOUR 1 trial. The Detour procedure uses …See details»
PQ Bypass Releases Positive 24-Month Data from the DETOUR1 …
Nov 13, 2020 Victoria Versprille [email protected] 908-328-5787. Release Summary. Promising long-term safety and effectiveness results from DETOUR1 Study, evaluating Detour …See details»